These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38641699)

  • 1. Knockdown of SETD5 Inhibits Colorectal Cancer Cell Growth and Stemness by Regulating PI3K/AKT/mTOR Pathway.
    Zhou X; Chen W; Zhuang D; Xu G; Puyang Y; Rui H
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38641699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway.
    Chen Q; Sun Z; Li J; Zhang D; Guo B; Zhang T
    J Environ Pathol Toxicol Oncol; 2021; 40(2):55-63. PubMed ID: 33822517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SETD5 regulates the OGT-catalyzed O-GlcNAcylation of RNA polymerase II, which is involved in the stemness of colorectal cancer cells.
    Cho HI; Jo S; Kim MS; Kim HB; Liu X; Xuan Y; Cho JW; Jang YK
    Sci Rep; 2023 Nov; 13(1):19885. PubMed ID: 37963940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 10. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
    Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
    Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway.
    Shi J; Yu L; Zhu C; Zhong H
    Open Life Sci; 2023; 18(1):20220697. PubMed ID: 37941780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 15. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
    Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.
    Chen J; Shao R; Li F; Monteiro M; Liu JP; Xu ZP; Gu W
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1317-26. PubMed ID: 26399781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETD5-AS1 stimulates neuron death in stroke via promoting PTEN expression.
    Miao SY; Miao SM; Cui RT; Yu AL; Miao ZJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6035-6041. PubMed ID: 30280788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways.
    Wang R; Li S; Hou Q; Zhang B; Chu H; Hou Y; Ni C; Sun L; Ran Y; Zheng H
    Discov Oncol; 2023 Jul; 14(1):137. PubMed ID: 37490168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
    Lu T; Zhu Z; Wu J; She H; Han R; Xu H; Qin ZH
    Cell Commun Signal; 2019 Mar; 17(1):28. PubMed ID: 30902093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FABP4 Regulates Cell Proliferation, Stemness, Apoptosis, and Glycolysis in Colorectal Cancer via Modulating ROS/ERK/mTOR Pathway.
    Gao Y; Wang Y; Wang X; Ma J; Wei M; Li N; Zhao Z
    Discov Med; 2023 Jun; 35(176):361-371. PubMed ID: 37272103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.